Balyasny Asset Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-388,384
| Closed | -$13.4M | – | 1630 |
|
|
2020
Q3 | $13.4M | Buy |
388,384
+153,529
| +65% | +$5.29M | 0.1% | 263 |
|
|
2020
Q2 | $3.92M | Sell |
234,855
-174,721
| -43% | -$2.92M | 0.03% | 476 |
|
|
2020
Q1 | $5.91M | Buy |
409,576
+196,274
| +92% | +$2.83M | 0.07% | 328 |
|
|
2019
Q4 | $7.14M | Sell |
213,302
-460,465
| -68% | -$15.4M | 0.04% | 459 |
|
|
2019
Q3 | $14.1M | Buy |
673,767
+508,089
| +307% | +$10.6M | 0.1% | 290 |
|
|
2019
Q2 | $3.45M | Buy |
165,678
+133,765
| +419% | +$2.78M | 0.02% | 608 |
|
|
2019
Q1 | $713K | Sell |
31,913
-344,846
| -92% | -$7.7M | ﹤0.01% | 1002 |
|
|
2018
Q4 | $9.01M | Sell |
376,759
-26,280
| -7% | -$629K | 0.07% | 346 |
|
|
2018
Q3 | $11M | Buy |
403,039
+38,227
| +10% | +$1.04M | 0.05% | 386 |
|
|
2018
Q2 | $9.81M | Sell |
364,812
-352,063
| -49% | -$9.47M | 0.04% | 418 |
|
|
2018
Q1 | $22.8M | Buy |
+716,875
| New | +$22.8M | 0.1% | 264 |
|